Skip to main navigation Skip to search Skip to main content

A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer

  • Liow, Elizabeth (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date20/12/21 → 19/12/26

Keywords

  • phase 3 study
  • treatment safety
  • treatment efficacy
  • urothelial cancer
  • Randomised clinical trial

Clinical Trial Phase

  • Phase III (a & b)